Publications by authors named "Lisa Ferguson-Sells"

Claim this Profile
P
Population Pharmacokinetics of Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension: A Combined Adult/Pediatric Model.
Lisa Ferguson-Sells, Nieves Velez de Mendizabal, Baohui Li, David Small

Clin Pharmacokinet· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically based pharmacokinetic modeling of tadalafil to inform pediatric dose selection in children with pulmonary arterial hypertension.
Jessica Rehmel, Lisa Ferguson-Sells, Bridget L Morse, Baohui Li, Gemma L Dickinson

CPT Pharmacometrics Syst Pharmacol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics and Pharmacodynamics of the Neutralizing Antibodies Bamlanivimab and Etesevimab in Patients With Mild to Moderate COVID-19 Infection.
Emmanuel Chigutsa, Lisa O'Brien, Lisa Ferguson-Sells, Amanda Long, Jenny Chien

Clin Pharmacol Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of tadalafil in a paediatric population with pulmonary arterial hypertension: A multiple ascending-dose study.
David Small, Lisa Ferguson-Sells, Nagib Dahdah, Damien Bonnet, John Landry

Br J Clin Pharmacol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia.
Brian A Willis, Karen Sundell, D Richard Lachno, Lisa R Ferguson-Sells, Michael G Case

Alzheimers Dement (N Y)· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of pharmacokinetics, pharmacodynamics, safety, and tolerability of the amyloid β monoclonal antibody solanezumab in Japanese and white patients with mild to moderate alzheimer disease.
Kazunori Uenaka, Masako Nakano, Brian A Willis, Stuart Friedrich, Lisa Ferguson-Sells

Clin Neuropharmacol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and effects on plasma and cerebrospinal fluid amyloid-beta after inhibition of gamma-secretase.
Eric R Siemers, Robert A Dean, Stuart Friedrich, Lisa Ferguson-Sells, Celedon Gonzales

Clin Neuropharmacol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis